Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
Review of Chinese Drug Evaluation and Registration in 2016
The CDE recently released its 2016 Report on Drug Evaluation in China. The Annual Report describes the general situation of drug registration acceptance, review and appro... (3/22/2017)
   
China's Drugmakers Need a Panacea (3/17/2017)
A Better Pill from China - Chinese Pharma Firms Target the Global Market (3/17/2017)
Importance of Patents in Chinese Pharmaceutical Tendering (3/14/2017)
GSK Sued by Couple It Hired to Investigate Whistleblower in 2013 (3/14/2017)
China Pledges to Speed Up Approvals of Foreign Drugs (3/14/2017)
Analysis: China's Healthcare Reforms, A Blessing Or A Threat? (3/10/2017)
More Wealth, Less Health: The Changes Fuelling China's Drug Industry Boom (3/6/2017)
Another Shoe Yet to Drop despite Final Introduction of the 2017 NRDL (3/2/2017)
Good Times Ahead for Chinese Pharmaceutical Firms as Policy Environment Turns Favorable (2/28/2017)
Modular Bioprocess Facilities Expanding Capacity in China (2/28/2017)
China's New Two-Invoice System in Pharma Distribution Aims to Reduce Drug Prices and Compliance Risk (2/28/2017)
Solidiance's Latest White Paper: China's Healthcare Reforms, Who Will Survive? (2/23/2017)
Figuring Out Reimbursement Policies in China (2/21/2017)
China to Slash Drug Distribution Groups in Price Drive (2/21/2017)
China's State Council Announces Major Policies to Reform the Pharmaceutical Industry (2/21/2017)
Review of Chinese Drug Evaluation and Re...  (3/22/2017)
51 Chinese Pharma Entrepreneurs on The H...  (3/22/2017)
CFDA Announces Outcome of Past Policy Cl...  (3/22/2017)
State Council Amends Radioactive Drug Re...  (3/22/2017)
Ex-manufacturer Drug Price Tracing Polic...  (3/22/2017)
Upcoming Event: ChinaBio Partnering Foru...  (3/22/2017) (free)
U.S. Charges Two Chinese Healthcare Exec...  (3/21/2017) (free)
CFDA Releases List of Reference Formulat...  (3/20/2017)
CFDA Terminates Import of OM Pharma's Br...  (3/20/2017)
Top In-licensing and Overseas M&...  (3/19/2017)
18 Chinese Pharma Companies Launched IPO...  (3/19/2017)
Data Snapshot: Antidepressant Drug Consu...  (3/19/2017)
Snapshot of MNC Winners of New 2017 NRDL...  (3/19/2017)
Sleep Apnea A Growing Health Problem for...  (3/17/2017)
Suzhou Ribo Secures CNY 270M in Series B...  (3/17/2017) (free)
Global Pharmerging Market to Grow at a CAGR of 12.88% in...
PhRMA Urges USTR to Protect US Innovation Abroad
Trump Wants Big Pharma Cut Outsourcing and Prices, Promi...
Mergermarket: Global Pharma and Biotech M&A Feels th...
Trump Challenges Pharma Outsourcing, Unnerving Drug Make...
Data Snapshot: Antidepressant Drug Consumption in Urban Hospita...
Chinese Foreign Trade of Medicines and Health Products Flat in ...
Chinese Pharma Formulation Trade: Export Down, Import Up
Snapshot of Newly-added Western Medicines in 2017 NDRL
Snapshot of Approved Target-oriented Anticancers in China
Top In-licensing and Overseas M&A Deals in 2016
18 Chinese Pharma Companies Launched IPO in February
Snapshot of MNC Winners of New 2017 NRDL Listing
Suzhou Ribo Secures CNY 270M in Series B Financing Round
Novartis to Reduce Prices of Two Originator Drugs in China
Review of Chinese Drug Evaluation and Registration in 20...
CFDA Announces Outcome of Past Policy Cleanup
State Council Amends Radioactive Drug Regulation, Libera...
Ex-manufacturer Drug Price Tracing Policy Expected To Be...
CFDA Releases List of Reference Formulations for Generic...
U.S. Charges Two Chinese Healthcare Executives with $400M Fr...
SIPO: Chinese Patent Applications Grew 23.8% in 2016
China Cracks Down on First Pharma Antimonopoly Case in 2017
China Issues Five Year Plan for Intellectual Property Develo...
USTR Releases 2016 Report on China's WTO Compliance Highligh...
U.S. FDA Issues Warning to Fosun's API Subsidiary over D...
India Pressures CFDA to Act and Restore Supply of Rare D...
U.S. FDA Warns Suzhou PharmTech, Putting It on Import Al...
New Report: Prospects of Chinese API Industry Up in the ...
U.S. FDA Warns Chinese Heparin Producer Dongying Tiandon...
Chi-Med Announces Positive Phase III Results of Colorect...
Luye Pharma Obtains Clinical Trials Approval for Rivasti...
BeiGene Initiates First Pivotal Study in China with BTK ...
CFDA Accepts NDA of Ascletis’s Novel HCV Drug Denoprevi...
FibroGen's Roxadustat (FG-4592) Meets Primary Endpoints ...
Sleep Apnea A Growing Health Problem for the Chinese
NHFPC to Inspect 14 Major Hospitals in 2017
Premier Li Keqiang Highlights Direction of China Health ...
IDC: Top10 Predictions on Implications of Healthcare IT ...
MOHRSS Issues the 2017 Edition of NRDL with 339 Addition...
51 Chinese Pharma Entrepreneurs on The Hurun Global Rich L...
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Upcoming Event: ChinaBio Partnering Forum 2017
Upcoming Event: Pharma China Annual Forum 2017 in Shangh...
Upcoming Event: Negotiation with International Healthcar...
Upcoming Event: China Clinical Trials Leaders Summit 201...
Upcoming Event: 7th European Biosimilars Congress 2017
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Officially Publishes Chi...
  WiCON and PharmaGuys Launch Ph...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
  WiCON Publishes China Pharmace...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links